Continuous glucose monitoring versus conventional glucose monitoring in the ICU: A randomized controlled trial

被引：1

作者：

Chu, Chen ^{[1
]}

Li, Jian ^{[2
,3
]}

Yang, XiaoDong ^{[1
]}

Zhao, HuiJing ^{[1
]}

Wu, ZaiXian ^{[1
]}

Xu, RuoXin ^{[1
]}

Gao, JianLing ^{[1
,4
]}

机构：

[1] Soochow Univ, Affiliated Hosp 4, Dept Crit Care Med, 9 Chongwen Rd, Suzhou 215124, Jiangsu, Peoples R China

[2] Soochow Univ, Affiliated Hosp 4, Dept Anesthesiol, Suzhou, Jiangsu, Peoples R China

[3] Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Jiangsu, Peoples R China

[4] Soochow Univ, Affiliated Hosp 1, Dept Intens Care Unit Anesthesia, Suzhou, Jiangsu, Peoples R China

来源：

JOURNAL OF CRITICAL CARE | 2024年 / 84卷

关键词：

Continuous glucose monitoring system; Glycemic variability; Intensive care unit; Mortality; INTENSIVE INSULIN THERAPY; INFUSION PROTOCOL; GLYCEMIC CONTROL; ILL PATIENTS; VARIABILITY; MORTALITY;

D O I：

10.1016/j.jcrc.2024.154894

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Purpose: This study evaluated the clinical utility of continuous glucose monitoring system (CGMS) in critically ill patients. Methods: In this randomized controlled trial, we randomly assigned critically ill participants with diabetes or stress-induced hyperglycemia to the CGMS group (n = 48) or to the conventional point-of-care monitoring (POCM) group (n = 48). The glucose values and clinical outcome were compared between the two group. The primary endpoint was 28-day mortality after intensive care unit admission. Results: The 28-day mortality was not significantly different between the CGMS and POCM group (20.8% vs 31.3%, P = 0.25). The mean glucose, time-weighted average glucose, glucose standard deviation and time in range (3.9-10.0) were significantly improved in the CGMS group (all P < 0.05). Conclusion: Compared with conventional POCM, CGMS did not decrease the 28-day mortality in critically ill participants with diabetes or stress-induced hyperglycemia. But CGMS may improve the glycemic control and may be increasingly used in critically ill patients.

引用

页数：5

共 38 条

[1] Glucose variability is a marker for COVID-19 severity and mortality [J].

Abuhasira, Ran ;

Grossman, Alon .

ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (06) :856-862

[2] Glucose variability and mortality in patients with sepsis [J].

Ali, Naeem A. ;

O'Brien, James M., Jr. ;

Dungan, Kathleen ;

Phillips, Gary ;

Marsh, Clay B. ;

Lemeshow, Stanley ;

Connors, Alfred F., Jr. ;

Preiser, Jean-Charles .

CRITICAL CARE MEDICINE, 2008, 36 (08) :2316-2321

[3] Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2020 [J].

不详 .

DIABETES CARE, 2020, 43 :S193-S202

[4] Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: A clinical trial [J].

Bukara-Radujkovic, Gordana ;

Zdravkovic, Dragan ;

Lakic, Sinisa .

VOJNOSANITETSKI PREGLED, 2011, 68 (08) :650-654

[5] Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis [J].

Chao, Wen-Cheng ;

Tseng, Chien-Hua ;

Wu, Chieh-Liang ;

Shih, Sou-Jen ;

Yi, Chi-Yuan ;

Chan, Ming-Cheng .

ANNALS OF INTENSIVE CARE, 2020, 10 (01)

[6] Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept [J].

Davis, Georgia M. ;

Faulds, Eileen ;

Walker, Tara ;

Vigliotti, Debbie ;

Rabinovich, Marina ;

Hester, Joi ;

Peng, Limin ;

McLean, Barbara ;

Hannon, Patricia ;

Poindexter, Norma ;

Saunders, Petrena ;

Perez-Guzman, Citlalli ;

Tekwani, Seema S. ;

Martin, Greg S. ;

Umpierrez, Guillermo ;

Agarwal, Shivani ;

Dungan, Kathleen ;

Pasquel, Francisco J. .

DIABETES CARE, 2021, 44 (04) :1055-1058

[7] Glucose Variability: Where It Is Important and How to Measure It [J].

DeVries, J. Hans .

DIABETES, 2013, 62 (05) :1405-1408

[8] Variability of blood glucose concentration and short-term mortality in ctitically ill patients [J].

Egi, Moritoki ;

Bellomo, Rinaldo ;

Stachowski, Edward ;

French, Craig J. ;

Hart, Graerne .

ANESTHESIOLOGY, 2006, 105 (02) :244-252

[9] Intensive versus Conventional Glucose Control in Critically Ill Patients [J].

Finfer, S. ;

Blair, D. ;

Bellomo, R. ;

McArthur, C. ;

Mitchell, I. ;

Myburgh, J. ;

Norton, R. ;

Potter, J. ;

Chittock, D. ;

Dhingra, V. ;

Foster, D. ;

Cook, D. ;

Dodek, P. ;

Hebert, P. ;

Henderson, W. ;

Heyland, D. ;

McDonald, E. ;

Ronco, J. ;

Schweitzer, L. ;

Peto, R. ;

Sandercock, P. ;

Sprung, C. ;

Young, J. D. ;

Su, S. ;

Heritier, S. ;

Li, Q. ;

Bompoint, S. ;

Billot, L. ;

Crampton, L. ;

Darcy, F. ;

Jayne, K. ;

Kumarasinghe, V. ;

Little, L. ;

McEvoy, S. ;

MacMahon, S. ;

Pandey, S. ;

Ryan, S. ;

Shukla, R. ;

Vijayan, B. ;

Atherton, S. ;

Bell, J. ;

Hadfield, L. ;

Hourigan, C. ;

McArthur, C. ;

Newby, L. ;

Simmonds, C. ;

Buhr, H. ;

Eccleston, M. ;

McGuinness, S. ;

Parke, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1283-1297

[10] Mean amplitude of glycemic excursions in septic patients and its association with outcomes: A prospective observational study using continuous glucose monitoring [J].

Furushima, Nana ;

Egi, Moritoki ;

Obata, Norihiko ;

Sato, Hitoaki ;

Mizobuchi, Satoshi .

JOURNAL OF CRITICAL CARE, 2021, 63 :218-222

← 1 2 3 4 →